Physician profile
Sam Jin Yee
NPI 1093796484
$784.07
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $351 · 2021: $196.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $348.91 | 2019-2021 | |
| Glaxosmithkline, LLC. | $112.54 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $45.04 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $37.66 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $31.12 | 2020-2021 | |
| Amarin Pharma, INC. | $23.21 | 2019 | |
| Allergan, INC. | $21.49 | 2021 | |
| Dexcom, INC. | $20.64 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.85 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.63 | 2020 | |
| Scilex Pharmaceuticals INC. | $17.25 | 2019 | |
| Amgen INC. | $16.51 | 2019 | |
| Shire North American Group INC | $16.28 | 2019 | |
| Genentech USA, INC. | $15.73 | 2019 | |
| Alfasigma USA, INC. | $15.66 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.94 | 2021 | |
| Pfizer INC. | $12.61 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.